Effects of hepatic impairment on the metabolism of fructose and 5- fluorouracil, as studied in fatty liver models using in vivo 31P-MRS and 19F-MRS

Magnetic Resonance Imaging

Volumn 17, Issue 2, 1999, Pages 283-290

  Otsuka, Hideki ^a   Harada, Masafumi ^a   Koga, Keiko ^b   Nishitani, Hiromu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

5 Fluorouracil; 19F MRS; 31P MRS; Choline deficient; Fatty liver

Indexed keywords

FLUORINE; FLUOROURACIL; FRUCTOSE; PHOSPHORUS 31; RADIOISOTOPE;

ANIMAL MODEL; ARTICLE; BIOLOGICAL MODEL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG METABOLISM; EQUIPMENT; FATTY LIVER; FRUCTOSE METABOLISM; HISTOPATHOLOGY; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; LIPID COMPOSITION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RADIOISOTOPE DIAGNOSIS; RAT; TIME;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0032930131     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(98)00077-0     Document Type: Article

References (19)

1. Kachi K., Araki T., Uchiyama G. Effect of i.v. fructose load on the P-31 MR Spectrum of the cirrhotic liver. Jpn. J. Magn. Reson. Med. 2:1991;127-132.
2. 31Phosphorus spectroscopy. Hepatology. 15:1992;835-842.
3. 31P-NMR. Biochem. Biophys. Acta. 1117:1992;251-257.
4. 31P Magnetic Resonance spectroscopic studies of the hepatic response of healthy rats and rats with acute hepatic damage to fructose loading. Magn. Reson. Med. 31:1994;469-481.
5. 31P nuclear magnetic resonance study in vivo of metabolic abnormalities in rats with acute liver failure. NMR Biomed. 1:1988;67-73.
6. 19F-MRS of 5-fluorouracil. Magn. Reson. Med. 22:1991;499-504.
7. 19F MRS studies of fluoropyrimidine chemotherapy. A Review. NMR Biomed. 2:1989;133-141.
8. 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment. Cancer Res. 48:1988;1680-1688.
9. 19F NMR spectroscopy. Magn. Reson. Med. 19:1991;113-123.
10. 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma . Magn. Reson. Imaging. 12:1994;497-511.
11. Ghoshal A.K., Rushmore T.H., Buc-Calderon P., Roberfroid M., Farber E. Prevention by free radical scavenger AD5 of prooxidant effects of choline deficiency. Free Radical Bio. Med. 8:1990;3-7.
12. Chandar N., Lombardi B. Liver cell proliferation and incidence of hepatocellular carcinomas in rats fed consecutively a choline-devoid and a choline-supplemented diet. Carcinogenesis. 9:1988;259-263.
13. Rushmore T.H., Lim Y.P., Farber E., Ghoshal A.K. Rapid lipid peroxdation in the nuclear fraction of rat liver induced by a diet deficient in choline and methionine. Cancer Lett. 24:1984;251-255.
14. Longo R., Pollesello P., Ricci C., Masutti F., Kvam B.J., Bercich L.B., Croce L.S., Grigolato P., Paoletti S., Bernard B., Tiribelli C., Palma L.D. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J. Magn. Reson. Imaging. 5:1995;281-285.
15. Thomsen C., Becker U., Winkler K., Christoffersen P., Jensen M., Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn. Reson. Imaging. 12:1994;487-495.
16. 1H chemical shift selective magnetic resonance imaging and localized spectroscopic methods. Magn. Reson. Imaging. 10:1992;663-677.
17. Shibayama Y. Localization of vascular resistance and significance of hepatic artery playing for development of portal hypertension in the choline deficient diet induced rat liver cirrhosis. Kannzo. 16:1975;332-340.
18. Terrier F., Vock P., Cotting J., Ladebeck R., Reichen J., Hentschel D. Effect of i.v.fructose on the P-31 MR spectrum of the liver Dose response in healthy volunteers . Radiology. 171:1989;557-563.
19. 19F-MRS observation of 5-FU metabolism in fatty liver induced by choline-deficient diet. Jpn. J. Mag. Res. Med. 16:1996;167-175.